Coral Laboratories Limited (BSE: 524506)
Health Care · Pharmaceuticals · IN
Rs650.10
+13.13% today · +37.6% 1Y
Coral Laboratories Limited (BSE: 524506) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $24.27M.
Over the last twelve months the share price has gained 37.6%, trading between 360.00 and 679.00.
Tweenvest scores Coral Laboratories Limited across four factors: quality 72/100, value 52/100, growth 0/100, dividend 40/100. Its strongest factor is quality.
524506 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.27M
- Revenue (TTM)
- $10.23M
- P/E
- 12.10
- EPS
- 53.75
- Dividend yield
- 0.31%
- Beta (5Y)
- 0.84
- 52-week high
- Rs679.00
- 52-week low
- Rs360.00
- Avg volume (3M)
- —
- Shares outstanding
- 3.57M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.